PubMed

Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity.

Tarnow I, Michelson AD, Barnard MR, Frelinger AL 3rd, Aasted B, Jensen BR, Parving HH, Rossing P, Tarnow L.

Platelets. 2009 Nov;20(7):513-9.PMID: 19852691 [PubMed - in process]Related articles

Telomere length predicts all-cause mortality in patients with type 1 diabetes.

Astrup AS, Tarnow L, Jorsal A, Lajer M, Nzietchueng R, Benetos A, Rossing P, Parving HH.

Diabetologia. 2009 Oct 4. [Epub ahead of print]PMID: 19802713 [PubMed - as supplied by publisher]Related articles

Development and validation of GFR-estimating equations using diabetes, transplant and weight.

Stevens LA, Schmid CH, Zhang YL, Coresh J, Manzi J, Landis R, Bakoush O, Contreras G, Genuth S, Klintmalm GB, Poggio E, Rossing P, Rule AD, Weir MR, Kusek J, Greene T, Levey AS.

Nephrol Dial Transplant. 2009 Sep 30. [Epub ahead of print]PMID: 19793928 [PubMed - as supplied by publisher]Related articles

Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria.

Persson F, Rossing P, Reinhard H, Juhl T, Stehouwer CD, Schalkwijk C, Danser AH, Boomsma F, Frandsen E, Parving HH.

Diabetes Care. 2009 Oct;32(10):1873-9. Epub 2009 Jul 8.PMID: 19587362 [PubMed - in process]Related articles

Autoregulation of glomerular filtration rate during spironolactone treatment in hypertensive patients with type 1 diabetes: a randomized crossover trial.

Schjoedt KJ, Christensen PK, Jorsal A, Boomsma F, Rossing P, Parving HH.

Nephrol Dial Transplant. 2009 Nov;24(11):3343-9. Epub 2009 Jun 26.PMID: 19561152 [PubMed - in process]Related articles

Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes.

Lund SS, Tarnow L, Astrup AS, Hovind P, Jacobsen PK, Alibegovic AC, Parving I, Pietraszek L, Frandsen M, Rossing P, Parving HH, Vaag AA.

Diabetes Obes Metab. 2009 Oct;11(10):966-77. Epub 2009 Jun 25.PMID: 19558610 [PubMed - in process]Related articles

[Hypertension in patients with diabetes]

Poulsen PL, Hansen KW, Gaede PH, Rossing P.

Ugeskr Laeger. 2009 Jun 8;171(24):2031-4. Danish. PMID: 19523370 [PubMed - indexed for MEDLINE]Related articles

Tubular and glomerular injury in diabetes and the impact of ACE inhibition.

Nielsen SE, Sugaya T, Tarnow L, Lajer M, Schjoedt KJ, Astrup AS, Baba T, Parving HH, Rossing P.

Diabetes Care. 2009 Sep;32(9):1684-8. Epub 2009 Jun 5.PMID: 19502542 [PubMed - indexed for MEDLINE]Related articles

Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study.

Hovind P, Rossing P, Tarnow L, Johnson RJ, Parving HH.

Diabetes. 2009 Jul;58(7):1668-71. Epub 2009 May 1.PMID: 19411615 [PubMed - indexed for MEDLINE]Related articlesFree article

[Clinical assessment of excretory renal function]

Petersen LJ, Birn H, Ladefoged SA, Randers E, Rehling M, Reinholdt B, Rossing P.

Ugeskr Laeger. 2009 Mar 23;171(13):1090. Danish. No abstract available. PMID: 19321085 [PubMed - indexed for MEDLINE]Related articles

Follow-up of intensive glucose control in type 2 diabetes.

Lund SS, Rossing P, Vaag AA.

N Engl J Med. 2009 Jan 22;360(4):416; author reply 418. No abstract available. PMID: 19164195 [PubMed - indexed for MEDLINE]Related articles

Is renal Na+,K+-ATPase a new target for renin-angiotensin blocking agents in diabetic nephropathy?

Rossing P.

J Physiol. 2008 Nov 15;586(Pt 22):5283. No abstract available. PMID: 19011129 [PubMed - indexed for MEDLINE]Related articlesFree article

Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial.

Schjoedt KJ, Astrup AS, Persson F, Frandsen E, Boomsma F, Rossing K, Tarnow L, Rossing P, Parving HH.

Diabetologia. 2009 Jan;52(1):46-9. Epub 2008 Oct 31.PMID: 18974967 [PubMed - indexed for MEDLINE]Related articles

YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.

Rathcke CN, Persson F, Tarnow L, Rossing P, Vestergaard H.

Diabetes Care. 2009 Feb;32(2):323-8. Epub 2008 Oct 28.PMID: 18957531 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study.

Lund SS, Tarnow L, Astrup AS, Hovind P, Jacobsen PK, Alibegovic AC, Parving I, Pietraszek L, Frandsen M, Rossing P, Parving HH, Vaag AA.

PLoS One. 2008;3(10):e3363. Epub 2008 Oct 9.PMID: 18852875 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy.

Jorsal A, Tarnow L, Flyvbjerg A, Parving HH, Rossing P, Rasmussen LM.

Diabetologia. 2008 Nov;51(11):2100-7. Epub 2008 Aug 22.PMID: 18719882 [PubMed - indexed for MEDLINE]Related articles

Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study.

Persson F, Rossing P, Hovind P, Stehouwer CD, Schalkwijk CG, Tarnow L, Parving HH.

Scand J Clin Lab Invest. 2008;68(8):731-8.PMID: 18609080 [PubMed - indexed for MEDLINE]Related articles

Elevated levels of high-molecular-weight adiponectin in type 1 diabetes.

Leth H, Andersen KK, Frystyk J, Tarnow L, Rossing P, Parving HH, Flyvbjerg A.

J Clin Endocrinol Metab. 2008 Aug;93(8):3186-91. Epub 2008 May 27.PMID: 18505763 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy.

Jorsal A, Tarnow L, Frystyk J, Lajer M, Flyvbjerg A, Parving HH, Vionnet N, Rossing P.

Kidney Int. 2008 Sep;74(5):649-54. Epub 2008 May 21.PMID: 18496510 [PubMed - indexed for MEDLINE]Related articles

Urinary proteomics in diabetes and CKD.

Rossing K, Mischak H, Dakna M, Zürbig P, Novak J, Julian BA, Good DM, Coon JJ, Tarnow L, Rossing P; PREDICTIONS Network.

J Am Soc Nephrol. 2008 Jul;19(7):1283-90. Epub 2008 Apr 30.PMID: 18448586 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term prevention of diabetic nephropathy: an audit.

Schjoedt KJ, Hansen HP, Tarnow L, Rossing P, Parving HH.

Diabetologia. 2008 Jun;51(6):956-61. Epub 2008 Apr 3.PMID: 18385971 [PubMed - indexed for MEDLINE]Related articles

Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy.

Nguyen TQ, Tarnow L, Jorsal A, Oliver N, Roestenberg P, Ito Y, Parving HH, Rossing P, van Nieuwenhoven FA, Goldschmeding R.

Diabetes Care. 2008 Jun;31(6):1177-82. Epub 2008 Mar 14.PMID: 18344285 [PubMed - indexed for MEDLINE]Related articlesFree article

Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes.

Persson F, Rossing P, Schjoedt KJ, Juhl T, Tarnow L, Stehouwer CD, Schalkwijk C, Boomsma F, Frandsen E, Parving HH.

Kidney Int. 2008 Jun;73(12):1419-25. Epub 2008 Mar 12.PMID: 18337712 [PubMed - indexed for MEDLINE]Related articles

Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.

Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P.

Diabetes Care. 2008 Jun;31(6):1170-6. Epub 2008 Mar 10.PMID: 18332153 [PubMed - indexed for MEDLINE]Related articlesFree article

ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy.

Parving HH, de Zeeuw D, Cooper ME, Remuzzi G, Liu N, Lunceford J, Shahinfar S, Wong PH, Lyle PA, Rossing P, Brenner BM.

J Am Soc Nephrol. 2008 Apr;19(4):771-9. Epub 2008 Jan 16.PMID: 18199798 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Lajer M, Tarnow L, Jorsal A, Teerlink T, Parving HH, Rossing P.

Diabetes Care. 2008 Apr;31(4):747-52. Epub 2007 Dec 27.PMID: 18162497 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.

Astrup AS, Nielsen FS, Rossing P, Ali S, Kastrup J, Smidt UM, Parving HH.

J Hypertens. 2007 Dec;25(12):2479-85.PMID: 17984670 [PubMed - indexed for MEDLINE]Related articles

Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy-a prospective follow--up study.

Astrup AS, Tarnow L, Christiansen M, Hansen PR, Parving HH, Rossing P.

Diabet Med. 2007 Dec;24(12):1381-5. Epub 2007 Oct 29.PMID: 17971180 [PubMed - indexed for MEDLINE]Related articles

Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudy.

Persson F, Rossing P, Hovind P, Stehouwer CD, Schalkwijk C, Tarnow L, Parving HH.

Diabetes. 2006 Dec;55(12):3550-5.PMID: 17130503 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history.

Rossing P.

Curr Diab Rep. 2006 Dec;6(6):479-83. Review.PMID: 17118233 [PubMed - indexed for MEDLINE]Related articles

Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction?

Rossing P, Parving HH, de Zeeuw D.

Nephrol Dial Transplant. 2006 Sep;21(9):2354-7; discussion 2357-8. Review. No abstract available. PMID: 16928724 [PubMed - indexed for MEDLINE]Related articlesFree article

Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy.

Schjoedt KJ, Rossing K, Juhl TR, Boomsma F, Tarnow L, Rossing P, Parving HH.

Kidney Int. 2006 Aug;70(3):536-42. Epub 2006 Jun 14.PMID: 16775595 [PubMed - indexed for MEDLINE]Related articles

Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy.

Schjoedt KJ, Lajer M, Andersen S, Tarnow L, Rossing P, Parving HH.

Scand J Clin Lab Invest. 2006;66(3):173-80.PMID: 16714246 [PubMed - indexed for MEDLINE]Related articles

Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy.

Rossing P, Rossing K, Gaede P, Pedersen O, Parving HH.

Diabetes Care. 2006 May;29(5):1024-30.PMID: 16644632 [PubMed - indexed for MEDLINE]Related articlesFree article

[ACE inhibitors and AT-II antagonists--do they protect against renal disease?]

Rossing P, Parving HH.

Ugeskr Laeger. 2006 Apr 10;168(15):1564; author reply1564-5. Danish. No abstract available. PMID: 16640990 [PubMed - indexed for MEDLINE]Related articles

Renoprotective effects of renin-angiotensin-system inhibitors.

Parving HH, Rossing P.

Lancet. 2006 Mar 18;367(9514):898-9; author reply 900-2. No abstract available. PMID: 16546532 [PubMed - indexed for MEDLINE]Related articles

Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes.

Rossing P, Cooper ME, Parving HH.

Diabetes Care. 2006 Mar;29(3):747-8; author reply 748-9. No abstract available. PMID: 16526122 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of renin angiotensin system blockade on night to day blood pressure ratio in diabetic nephropathy.

Jacobsen PK, Rossing P, Parving HH.

Nephrol Dial Transplant. 2006 Jul;21(7):2030-1. Epub 2006 Jan 31. No abstract available. PMID: 16449277 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH.

Diabetes Care. 2006 Feb;29(2):334-9.PMID: 16443883 [PubMed - indexed for MEDLINE]Related articlesFree article

Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005.

Rossing P.

Diabetologia. 2006 Jan;49(1):11-9. Epub 2005 Dec 9.PMID: 16341685 [PubMed - indexed for MEDLINE]Related articles

Beneficial impact of spironolactone in diabetic nephropathy.

Schjoedt KJ, Rossing K, Juhl TR, Boomsma F, Rossing P, Tarnow L, Parving HH.

Kidney Int. 2005 Dec;68(6):2829-36.PMID: 16316360 [PubMed - indexed for MEDLINE]Related articles

Progression of microalbuminuria in type 1 diabetes: ten-year prospective observational study.

Rossing P, Hougaard P, Parving HH.

Kidney Int. 2005 Oct;68(4):1446-50. No abstract available. PMID: 16164620 [PubMed - indexed for MEDLINE]Related articles

Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study.

Astrup AS, Tarnow L, Rossing P, Pietraszek L, Riis Hansen P, Parving HH.

Kidney Int. 2005 Sep;68(3):1250-7.PMID: 16105058 [PubMed - indexed for MEDLINE]Related articles

Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy.

Ahmed SB, Hovind P, Parving HH, Rossing P, Price DA, Laffel LM, Lansang MC, Stevanovic R, Fisher ND, Hollenberg NK.

Diabetes Care. 2005 Aug;28(8):1988-94.PMID: 16043743 [PubMed - indexed for MEDLINE]Related articlesFree article

The changing epidemiology of diabetic microangiopathy in type 1 diabetes.

Rossing P.

Diabetologia. 2005 Aug;48(8):1439-44. Epub 2005 Jun 29. Review.PMID: 15986235 [PubMed - indexed for MEDLINE]Related articles

Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy.

Andersen S, van Nieuwenhoven FA, Tarnow L, Rossing P, Rossing K, Wieten L, Goldschmeding R, Parving HH.

Kidney Int. 2005 Jun;67(6):2325-9.PMID: 15882275 [PubMed - indexed for MEDLINE]Related articles

Renoprotection with and without blood pressure reduction.

Laverman GD, Andersen S, Rossing P, Navis G, de Zeeuw D, Parving HH.

Kidney Int Suppl. 2005 Apr;(94):S54-9.PMID: 15752241 [PubMed - indexed for MEDLINE]Related articles

Telmisartan vs. enalapril in type 2 diabetes.

Parving HH, Hovind P, Rossing P.

N Engl J Med. 2005 Feb 24;352(8):835-6; author reply 835-6. No abstract available. PMID: 15736292 [PubMed - indexed for MEDLINE]Related articles

[Risk factors for the development of microalbuminuria in type 1 diabetes: an incidence cohort study--a secondary publication]

Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, Binder C, Parving HH.

Ugeskr Laeger. 2005 Jan 3;167(1):57-60. Danish. No abstract available. PMID: 15675170 [PubMed - indexed for MEDLINE]Related articles

Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.

Schjoedt KJ, Andersen S, Rossing P, Tarnow L, Parving HH.

Diabetologia. 2004 Nov;47(11):1936-9. Epub 2004 Nov 17.PMID: 15551047 [PubMed - indexed for MEDLINE]Related articles